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ABSTRACT
Objective This study aimed to examine the long- term 
outcomes and health- related quality of life in patients 
with blunt thoracic injuries over 6 months from hospital 
discharge and develop models to predict long- term 
patient- reported outcomes.
Design A prospective observational study using 
longitudinal survey design.
Setting The study recruitment was undertaken at 12 
UK hospitals which represented diverse geographical 
locations and covered urban, suburban and rural areas 
across England and Wales.
Participants 337 patients admitted to hospital with 
blunt thoracic injuries were recruited between June 
2018–October 2020.
Methods Participants completed a bank of two quality 
of life surveys (Short Form-12 (SF-12) and EuroQol 
5- Dimensions 5- Levels) and two pain questionnaires (Brief 
Pain Inventory and painDETECT Questionnaire) at four time 
points over the first 6 months after discharge from hospital. 
A total of 211 (63%) participants completed the outcomes 
data at 6 months after hospital discharge.
Outcomes measures Three outcomes were measured 
using pre- existing and validated patient- reported outcome 
measures. Outcomes included: Poor physical function 
(SF-12 Physical Component Score); chronic pain (Brief 
Pain Inventory Pain Severity Score); and neuropathic pain 
(painDETECT Questionnaire).
Results Despite a trend towards improving physical 
functional and pain at 6 months, outcomes did not return 
to participants perceived baseline level of function. 
At 6 months after hospital discharge, 37% (n=77) of 
participants reported poor physical function; 36.5% (n=77) 
reported a chronic pain state; and 22% (n=47) reported 
pain with a neuropathic component. Predictive models 
were developed for each outcome highlighting important 
data collection requirements for predicting long- term 
outcomes in this population. Model diagnostics including 
calibration and discrimination statistics suggested good 
model fit in this development cohort.
Conclusions This study identified the recovery 
trajectories for patients with blunt thoracic injuries over 
the first 6 months after hospital discharge and present 
prognostic models for three important outcomes which 
after external validation could be used as clinical risk 
stratification scores.
BACKGROUND
Blunt thoracic injury (BTI) is a term that 
covers a spectrum of different injury patterns 
and severities across all adult age groups.1 It 
accounts for about 15% of injured patients 
Strengths and limitations of this study
 ► This study highlights the physical and pain sequelae 
associated with recovery after blunt thoracic injuries 
and provides insights into the recovery trajectory for 
this population.
 ► The study highlights the complexity of developing 
prognostic models for long- term outcomes after 
blunt thoracic injuries and acknowledges the limited 
current clinical utility in predictive models presented 
in this study.
 ► The longitudinal study design using patient- reported 
outcome measures (PROMs) demonstrates the im-
portance of eliciting health data from this population 
over throughout the post discharge recovery period.
 ► Missingness within follow- up data set is a limitation 
to the prognostic modelling process.
 ► Despite the benefits of PROMs, it is important to ac-
knowledge the potential inherent bias within these 
measures.
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presenting to trauma hospitals, with mortality rates 
reported between 4%–20%.2 Outcomes within trauma 
care have historically been measured primarily using 
mortality as a key outcome.3 During the last two decades, 
there has been a decrease in the mortality rates of patients 
with polytrauma in high- income countries with organised 
trauma systems.4 As the mortality rates have decreased, 
there has been a growing focus on measuring outcomes 
relating to injury morbidity.3 5 There is a growing body 
of international research investigating the long- term 
outcomes of patients with BTI, but within the UK, there is 
a paucity of BTI outcomes research with little consistency 
in the methods employed.6 7
For patients recovering from BTI, it has been identified 
that reduced physical function, persistent altered respi-
ratory function and chronic pain frequently impact on 
all aspects of daily living.6 Health- related quality of life 
(HRQoL) provides a strong foundation for measuring 
the impact of these symptoms with a holistic and compre-
hensive approach.8 It is important not to isolate individual 
components of daily living but consider them as a single 
entity, and HRQoL measurement provides a vehicle to do 
this.9 Furthermore, it allows the development of theory 
driven interventions that impact on all elements of daily 
living.10 For the purposes of this study HRQoL is defined 
as including all aspects of self- perceived well- being that 
are related to, or affected by, the presence of disease or 
treatment.11
Follow- up after hospital discharge with major trauma 
is often limited within the UK’s National Health Service 
(NHS), resulting in limited clinical knowledge about the 
recovery journey of patients with BTI.12 This also leaves 
clinicians without a trajectory for recovery making it very 
difficult to adequately educate and prepare patients for 
self- management in the post hospital discharge recovery 
period.13 Evidence from this study will be used to facili-
tate the identification of patients at risk of poor outcomes 
after BTI, help develop health promotion materials and 
to support the development of follow- up interventions 
within BTI management.13
Having the ability to predict outcomes and develop 
methods for risk stratification is extremely important 
in trauma care.14 There is a growing body of prognostic 
research in this area with simple scoring systems devel-
oped and validated with effective predictive abilities across 
different health systems.2 Where resources for patient 
follow- up are limited, it is key that effective methods for 
identifying patients in high- risk groups for complications 
or poor outcomes are in place, allowing resources to be 
focused on these patients at the greatest risk. The aim of 
this study was to examine the long- term outcomes and 
HRQoL in patients with BTI over 6 months from hospital 
discharge and develop models to predict long- term patient- 
reported outcomes. Study objectives were as follows:
 ► Investigate changes in HRQoL over 6 months after 
hospital discharge with BTI.
 ► Examine the evolution of pain and neuropathic pain 
over 6 months after discharge from hospital with BTI.
 ► Develop predictive models for poor physical func-
tioning, chronic pain and neuropathic pain at 
6 months after hospital discharge with BTI.
METHODS
This prospective multicentred observational study 
employed longitudinal survey methods to follow- up 
patients recovering from BTI over a 6- month period from 
hospital discharge. This research forms the quantita-
tive component of a mixed methods study investigating 
recovery after BTI. The qualitative components will be 
reported separately.15
Study setting
The study population sample was recruited from major 
trauma centres (Level 1) (n=5) and trauma units (Level 
2–3) (n=7) from diverse geographical locations within 
urban, suburban and rural areas across England and 
Wales. Sites were set up in a stepwise fashion and in total 
12 acute hospital sites recruited participants between 
6–10 months in two separate recruitment cohorts between 
June 2018 and March 2020.
Eligibility criteria
Inclusion criteria
 ► Participant is willing and able to give informed 
consent for participation in the study
 ► Male or female, aged 16 years or above
 ► Admitted to a major trauma centre/trauma unit with 
primary BTI.
 ► Admitted to hospital for a period of 24 hours or 
greater.
Exclusion criteria
 ► Unstable spinal fracture or spinal cord injury.
 ► Traumatic brain injury with cognitive impairment
 ► Altered mental status that would prevent accurate 
self- assessment through questionnaires or prevent 
informed consent into study
 ► Associated unstable pelvic fracture or open abdomen 
requiring extended periods of treatment in hospital
 ► Limb injuries from same traumatic event that require 
surgical intervention
 ► Participant is a prisoner/in police custody at the time 
of recruitment.
Data collection
Data collection was undertaken at four time points: (1) 
Hospital discharge (including a pre- injury estimation of 
HRQoL); (2) 1 month after discharge; (3) 3 months after 
discharge; and (4) 6 months after discharge. Potential 
participants were identified by the local clinical team or 
the clinical research nurses at each site. Demographic and 
injury- related data were collated throughout the acute 
admission using a previously tested case report form,1 and 
site staff conducted data collection at hospital discharge. 
Post discharge follow- up was conducted by the central 
research team at the host university using either postal 
surveys or electronic surveys hosted by SurveyMonkey. 
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During post discharge follow- up non- responding partic-
ipants were contacted up to three times using a mixed 
multimedia approach including telephone, post or email, 
to maximise participation and minimise the potential for 
missing data.
Ethics considerations
Formal informed written consent was taken from all 
participants after information sheets had been provided 
and sufficient time was allowed for discussion with family 
and clinical research staff. Participants were informed 
that everyone who completed data collection at all time 
points would be placed in a prize draw to win a £50 shop-
ping voucher to recognise the time associated with partic-
ipation in this longitudinal follow- up study.
Sample size
This observational study had an exploratory design and 
pragmatic approach to sample size. Although there is no 
consensus on the sample requirements for logistic regres-
sion analysis, based on previous studies we aimed to have 
10 events for each predictor variables included in the 
model.2 3 As it was likely that 10 predictor variables would 
be used in the modelling process for each model, the aim 
was to achieve 100 events (ie, outcomes of interest) in the 
sample.
Outcome measures
HRQoL was explored first at a global level through the 
Physical Component Score (PCS) and Mental Compo-
nent Score (MCS) of the Short Form-12 (SF-12),16 
and second, using the individual levels of the EuroQol 
5- Dimensions 5- Levels (EQ- 5D- 5L).17 18 Pain was previ-
ously recognised as an ongoing problem throughout post 
hospital discharge recovery.6 In this study, pain severity 
and impact were measured using the Brief Pain Inventory 
(BPI)19 and neuropathic pain was assessed using the pain-
DETECT Score20 Using existing literature on HRQoL 
after BTI,6 21 three key outcomes were selected:
1. Physical Function is an individual’s ability to undertake 
actions that involve physical activities, ranging from ac-
tivities of daily living to more complex activities that 
involve a combination of skills, often within a social 
context.3 For the purposes of this study, physical func-
tioning was measured using the PCS of the SF-12 at 
6 months after discharge from hospital. A PCS of ≤35 
(range: 0–100 with higher scores equalling better phys-
ical function) was taken as defining poor physical func-
tioning from previous literature.16
2. Chronic Pain is defined as pain that persists beyond 
the normal expected healing time and therefore lacks 
the acute warning function of physiological nocicep-
tion. Pain is normally considered as chronic when it 
lasts or recurs for more than 3–6 months.22 For this 
study, chronic pain was defined as having a BPI Pain 
Severity Score (PSS) of ≥3.5 (range: 0–10 and higher 
scores equals increased pain severity) at 6 months after 
hospital discharge.23
3. Neuropathic pain is defined as pain caused by a lesion 
or disease of the somatosensory nervous system.24 For 
the purposes of this study, participants with a poten-
tial neuropathic pain component were identified using 
the painDETECT Questionnaire (PDQ).20 A painDE-
TECT score ≥12 (range: −1 to 38) at 6 months after 
hospital discharge defined our cohort of patients with 
a potential neuropathic pain component.25
Although the limitations of using binary outcome meas-
ures were acknowledged in the planning phase, this was 
an important component in the process of developing 
prognostic models which could be used as risk stratifica-
tion scores in the clinical practice setting.
Selection of candidate predictor variables
A collection of predictor variables was required which 
covered multiple potentially influential factors relating to 
the outcomes of interest. Initially, during the study devel-
opment, a long list of candidate variables were selected 
from previous literature.6 10 26 27 From this long- list, 
shortlists of variables for each outcome were compiled. 
Decision- making for entering variables into the model-
ling process was based on their clinical significance and 
achieving statistical significance at the 5% level in the 
univariate analysis phase. There was an ‘a priori’ plan 
for candidate variables to be selected in three phases, 
initially using only variables that are readily available in 
clinical practice, then using variables that are currently 
not readily available in clinical practice and finally using 
variables collected at post discharge time points.
Statistical analysis
Data analysis was undertaken using SPSS V.26. Statis-
tical data were presented using descriptive and inferen-
tial statistical methods and reported according to the 
Strengthening the Reporting of Observational Studies in 
Epidemiology statement.28 Binary and categorical data 
were presented as percentages and number of cases. 
Continuous data were presented as means with SD. The 
statistical tests applied for binary/categorical data were χ2 
test of association, except where the expected cell counts 
were ≤5 when the Fisher’s exact test was used. Compar-
isons continuous data from two independent groups 
was undertaken using the Student’s t- test. Longitudinal 
changes in continuous variables over the course of the 
post discharge follow- up period are reported at a group 
level. This uses the longitudinal change in the group 
mean from one time point to the next to measure change.
Missing data were addressed using the multiple impu-
tation procedure in SPSS. Most missing data were found 
within the follow- up phase of data collection where units 
of data (ie, surveys) were not returned. The imputation 
model included all predictor variables with potential 
for inclusion in the modelling process including candi-
date predictor variables from within the hospital admis-
sion and from the post discharge follow- up. A total of 10 
imputed data sets were created. Longitudinal imputation 
of outcome variables was considered but not conducted 
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in this study due to the high level of missingness at both 
1 month and 3 months and the low number of partici-
pants who completed the follow- up data collection at all 
time points. Ultimately despite the potential limitations, 
a case wise approach was used.
The predictive model framework was developed in 
accordance with the TRIPOD (Transparent Reporting of 
multivariable predication model for Individual Prognosis 
Or Diagnosis) methodology29 and the study methods 
based on previously published prognostic modelling 
studies.2 3 30 A multivariable logistic regression analysis 
was used to evaluate the association of the predictors with 
the outcome (dependent variable) in each imputed data 
set using the forward stepwise method.31 In this process, 
SPSS automatically produced a final model that aggre-
gated the results across all the imputed data sets.
Calibration was evaluated using a Hosmer- Lemeshow 
test where a p value>0.05 was considered to represent 
good calibration. In addition, graphical calibration plots 
were developed. A receiver operating characteristic 
(ROC) curve was plotted for each model. A c- statistic 
(area under the receiver operator curve) was calculated, 
that tested whether the amount of discrimination was 
significantly different from random (c- statistic of 0.5 indi-
cates that discrimination is no better than the toss of a 
coin). Performance of the final model was assessed using 
sensitivity and specificity.32 Throughout statistical signifi-
cance was recognised at the 5% level (p<0.05).
Patient and public involvement
A patient and public reference group was formed and 
involved in the development phases of this study including 
during protocol development and application for ethical 
approval but have not been involved in data collection, 
analysis, or interpretation.
RESULTS
A total of 337 patients were recruited to the study. The 
mean age of participants was 62 years (±16.5) and 69% 
(n=231) were men. The predominant mechanism of 
injury was falls <2 m (45%, n=153) and the mean number 
of rib fractures was 5.2 (±4). At 6 months after discharge, 
37% (n=77) of the sample self- reported poor physical 
functioning, 37% (n=77) reported chronic pain and 
22% (n=47) reported pain with a likely neuropathic 
pain component. Table 1 summarises key demographic 
data for the total sample. Further greater detailed demo-
graphic data are presented in online supplemental table 
S1 as a supplementary file to this study.
Missing data analysis
Overall, the combined response rate at all time points was 
72%. At hospital discharge 95% (n=320) completed the 
discharge data collection time point, subsequently, 62% 
(n=210) and 43% (n=144) completed data collection 
at 1 month and 3 months after discharge, respectively. 
At 6 months, 63% (211) of the total sample completed 
follow- up where the study outcomes data were collected. 
Of the 211 participants who completed the 6- month 
follow- up, n=200 (94%) completed discharge data collec-
tion, 174 (82%) completed the 1 month data collection 
time point and 142 (67%) completed data collection at 
3 months after discharge.
Overall missingness within the data set was predomi-
nately from ‘unit missing data’ (ie, completed survey not 
returned by participant) as individual items of missing 
data within a returned survey were followed up with partic-
ipants at the time of data collection. Among candidate 
predictor variables 17% (n=37) were missing at 1 month 
follow- up, and 33% (n=69) at 3 months. Although this 
represents high levels of missingness within the data set, 
this is not uncommon in longitudinal follow- up studies 
after traumatic injuries .6
A missing data analysis was undertaken as part of the 
analysis process to identify any differences in the char-
acteristics of participants who did or did not respond 
to follow- up at 6 months after hospital discharge when 
outcome data were collected. Online supplemental table 
S2 presents the results from this analysis. Although there 
was a statistically significant difference in participants 
age, incidence of cardiac disease and cancer and MCS at 
the pre- injury, discharge and 1 month post discharge time 
point, these were not deemed to be clinically significant 
differences. Furthermore, a logistic regression model was 
built using a stepwise forward approach using variables 
identified in the univariable analysis of missingness to 
identify predictors of responder status at 6 months after 
discharge. It was not possible to fit a model using the 
selected variables and no statistically significant predic-
tors were identified. Since none were identified, it was 
assumed that the two groups were characteristically 
similar and therefore a sensitivity analysis, using weights 
calculated from the logistic regression model, was not 
undertaken. Based on Little and Rubin’s taxonomy miss-
ingness was assumed to be missing at random (MAR) at 
the unit level and multiple imputation methods in SPSS 
were used to address item level missingness .33 34
Changes in HRQoL over 6 months after discharge from 
hospital
Physical function was clearly affected by the injuries 
experienced by this cohort. Measures of HRQoL are 
presented in table 2. As expected, the mean PCS score 
(SF-12) saw a 19.3% (46.5–27.2) drop from the pre- 
injury estimate through to the initial hospital discharge 
time point representing a substantial negative change in 
physical functioning. Over the 6- month follow- up there 
were incremental improvements in the mean PCS score 
(31.6, 40.1 and 41.7 at 1, 3 and 6 months, respectively) 
but the sample failed to return to their baseline esti-
mate of physical function (−4.8%) or population norms 
(−8.3%) within the 6- month follow- up period. During the 
same time frame, the impact of injury on mental health 
was lesser than on physical function. The mean MCS 
score (SF-12) dropped from 49.7 to 44.4 (–5.3) from the 
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pre- injury estimate through to hospital discharge, drop-
ping a further 0.5% to 43.9 at 1 month after hospital 
discharge. Between the 1 and 6 months the mean MCS 
increased to 47.8 which remained 1.9% below the pre- 
injury estimate and 2.2% below the population norms for 
England.
The impact of BTI on individual components of 
HRQoL were measured using the EQ- 5d- 5L question-
naire. Table 3 presents the individual dimension/level 
data for each time point. At hospital discharge, the lowest 
scored (best) dimension was anxiety and depression 
with 43% of the sample reporting no problems in this 
dimension. At 6 months after discharge: ‘Mobility’, ‘Self- 
Care’, ‘Usual Activities’ and ‘Anxiety/Depression’ were 
the best rated dimensions, with between 42% and 73% 
of the sample reporting no problems in these areas. The 
highest scoring (worst) dimensions at hospital discharge 
were ‘Usual Activities’ where 42% (n=135) reported 
being wholly unable to complete usual activities. Between 
42%–43% of the sample reported moderate (3), severe 
(4) or extreme (5) pain at both 3 months and 6 months 
after discharge from hospital (42.3% (n=61) at 3 months 
and 43.1% (n=91) at 6 months). At 6 months after injury, 
there was a proportion of participants who reported 
severe or extreme problems in all dimensions, and these 
exceeded the pre- injury estimated levels. This demon-
strates that although the 6- month follow- up period was 
sufficient to observe recovery in a vast proportion of this 
sample, there were participants who reported extreme 
disability beyond the follow- up.
Evolution of chronic pain and pain with a neuropathic 
component
Subjective pain evaluated through the BPI PSS reflects 
the persistent levels of pain experienced by study partic-
ipants throughout the 6- month study follow- up period. 
Pain- related outcome measures are presented in table 2. 
Although there were consistent incremental reductions 
in the mean pain score over time, at 6 months after injury 
the mean pain severity score was 2.7 (SD 2.7); 36.5% 
(n=77) of participants were reporting chronic pain. The 
mean BPI Pain Interference Score (PIS) also demon-
strated incremental decreases until the 3- month time 
point where there appears to be a plateau, followed by a 
marginal deterioration of the mean PIS (2.6 (SD 2.7) to 
2.7 (SD 2.9)). This highlights that participants reporting 
pain that impacted on daily activities at 3 months were 
likely to continue to experience these interferences at 
6 months after hospital discharge. Similarly, mean self- 
reported analgesic effectiveness decreased from 65.3 (SD 
24.8) at hospital discharge to 46.5 (SD 35.8) at 3 months 
which then plateaued and was 49.2 (SD 33.4) at 6 months 
after hospital discharge. Individual components of the 
BPI PSS and BPI PIS can be seen in the online supple-
mental tables S3 and S4.
At hospital discharge and 1 month after, 30.6% (n=98) 
and 32.4% (68%) (respectively) of patients reported 
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component. At 3 months and 6 months, there was a 
reduction in the number of participants reporting neuro-
pathic pain (23.6% (n=34) and 22.3% (n=47), respec-
tively, with 13.2% (n=19) and 9.0% (n=19), respectively, 
reporting painDETECT scores in the high- risk category 
(representing 90% likelihood of having a neuropathic 
pain component).
Development of predictive models for the three outcomes of 
interest
Table 4 highlights three models developed in this study, 
one for each outcome. Initially candidate predictors were 
selected from variables readily available within the inpa-
tient clinical journey (including hospital discharge), as 
this would be most useful in clinical practice. Unfortu-
nately, we were unable to isolate a model with acceptable 
levels of discrimination and calibration using these vari-
ables alone. In a second approach models were developed 
using variables from the post discharge follow- up period 
(table 4). Three models with acceptable levels of cali-
bration and discrimination were identified. All models 
require measures collected at hospital discharge, 1 month, 
and 3 months after discharge to predict the outcomes of 
interest.
Model 1: Poor physical function at 6 months after 
hospital discharge was predicted using the following: the 
combination of the measures of physical function both 
prior to injury and at 3 months after injury, a measure-
ment of pain levels at 1 month after discharge and a 
measurement of the impact of pain on the individuals 
walking ability at hospital discharge. Model 2: It was 
possible to predict chronic pain at 6 months after hospital 
discharge using the following variables: Pre- injury regular 
use of analgesic agents, measures of physical function 
before the injury and at 3 months after discharge and a 
Table 3 Individual dimension and level data from EuroQoL 5- Dimensions (5- Levels)
(n= (%)) No problems Slight problems Moderate problems Severe problems Unable/extreme problems
Mobility:
  Pre- injury 204 (60.5) 50 (14.8) 47 (13.9) 33 (9.8) 3 (0.9)
  Discharge 50 (15.6) 78 (24.4) 102 (31.9) 72 (22.5) 18 (5.6)
  1 month 65 (31) 76 (36.2) 38 (18.1) 26 (12.4) 5 (2.4)
  3 months 71 (49.3) 36 (25) 17 (11.8) 16 (11.1) 4 (2.8)
  6 months 110 (52.1) 41 (19.4) 32 (15.2) 23 (10.9) 5 (2.4)
Self- care:
  Pre- injury 269 (79.8) 33 (9.8) 23 (6.8) 10 (3) 2 (0.6)
  Discharge 68 (21.3) 92 (28.8) 81 (25.3) 59 (18.4) 20 (6.3)
  1 month 108 (51.4) 59 (28.1) 30 (14.3) 10 (4.8) 3 (1.4)
  3 months 106 (73.6) 21 (14.6) 9 (6.3) 6 (4.2) 2 (1.4)
  6 months 153 (72.5) 31 (14.7) 20 (9.5) 5 (2.4) 2 (0.9)
Usual activities:
  Pre- injury 224 (66.5) 53 (15.7) 33 (9.8) 19 (5.6) 8 (2.4)
  Discharge 21 (6.6) 36 (11.3) 72 (22.5) 56 (17.5) 135 (42.2)
  1 month 20 (9.5) 95 (45.2) 41 (19.5) 29 (13.8) 25 (11.9)
  3 months 49 (34) 51 (35.4) 22 (15.3) 9 (6.3) 13 (9)
  6 months 89 (42.2) 62 (29.4) 34 (16.1) 14 (6.6) 12 (5.7)
Pain/discomfort:
  Pre- injury 157 (46.6) 94 (27.9) 61 (18.1) 18 (5.3) 7 (2.1)
  Discharge 14 (4.4) 41 (12.8) 151 (47.2) 74 (23.1) 40 (12.5)
  1 month 15 (7.1) 49 (23.3) 112 (53.3) 22 (10.5) 12 (5.7)
  3 months 37 (25.7) 46 (31.9) 47 (32.6) 10 (6.9) 4 (2.8)
  6 months 72 (34.1) 48 (22.7) 72 (34.1) 11 (5.2) 8 (3.8)
Anxiety/depression:
  Pre- injury 188 (55.8) 79 (23.4) 54 (16) 11 (3.3) 5 (1.5)
  Discharge 138 (43.1) 85 (26.6) 64 (20) 20 (6.3) 13 (4.1)
  1 month 100 (47.6) 38 (18.1) 57 (27.1) 7 (3.3) 8 (3.8)
  3 months 82 (56.9) 27 (18.8) 26 (18.1) 4 (2.8) 5 (3.5)
  6 months 119 (56.4) 42 (19.9) 33 (19.9) 8 (3.8) 9 (4.3)
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measurement of pain severity at 1 month and 3 months 
after discharge. Model 3: Neuropathic pain was predicted 
using the following variables: starting pregabalin during 
the acute hospital admission, the MCS at 1 month and 
the impact of pain on mood at 3 months after discharge, 
and the outcome of taking the PDQ at 3 months after 
discharge.
The ROC diagrams for each model are presented in 
figure 1. Figure 2 presents the graphitised calibration 
plots whereby plot points present risk of outcome in 
tenths of patients with similar predicted probabilities. 
The line highlights the relationship between the observed 
frequency and the predicted probability of developing a 
poor outcome. Model 1 for predicting poor physical func-
tioning at 6 months after discharge had a c- statistic (area 
under the receiver operator curve) of 0.846 (SE: 0.028; 
p<0.001; 95% CI 0.790 to 0.901) with a Hosmer and Leme-
show χ2 value of 5.570 (p=0.695) with 8 df, demonstrating 
acceptable goodness- of- fit. This resulted in a model with 
a sensitivity of 79% and a specificity of 81.2%. Model 2 
for predicting chronic pain at 6 months after discharge 
had a c- statistic of 0.878 (SE: 0.023; p<0.001; 95% CI 
0.833 to 0.923) with a Hosmer and Lemeshow χ2 value 
of 6.778 (p=0.561) with 8 df, also demonstrating accept-
able goodness- of- fit. This resulted in a model with a sensi-
tivity of 63.6% and a specificity of 86.5%. Finally, Model 
3 for predicting pain with a neuropathic component had 
a c- statistic of 0.910 (SE: 0.027;<0.001; 95% CI 0.857 to 
0.964) with a Hosmer and Lemeshow χ2 value of 2.221 
(p=0.912) with 8 df, demonstrating acceptable goodness- 
of- fit. This resulted in a model with a sensitivity of 61.3% 
and a specificity of 92.7%. The overall accuracy of models 
1–3 were 80.6%, 78.1% and 85.8%, respectively. The cali-
bration plots for each model (figure 2) demonstrated 
acceptable levels of calibration as many of the plots were 
close to the 45 degree line.
DISCUSSION
This study investigated changes in self- reported HRQoL 
and pain outcomes over a 6- month period from hospital 
discharges after BTI. The study has provided new insights 
Table 4 Predictive models for three outcomes of interest
Coefficient SE OR P value 95% CI
Model 1: poor physical function at 6 months after hospital discharge
Pre- injury PCS (range: 0–100) (one step increment increase) −0.093 0.019 0.911 <0.001 0.878 to 0.945
Current pain at 1 month after injury (range 0–10) (one step 
increment increase)
0.224 0.078 1.252 0.004 1.075 to 1.457
PCS at 3 months (range: 0–100) (one step increment 
increase)
−0.040 0.014 0.960 0.005 0.934 to 0.988
Impact of pain on walking at discharge (range: 0–10) (one 
step increment increase)
0.139 0.057 1.149 0.015 1.027 to 1.285
Constant 3.745 1.132 – 0.001 –
Model 2: chronic pain at 6 months after hospital discharge
Regular analgesia use before injury 1.813 0.533 6.130 0.001 2.158 to 17.414
Pre- injury PCS (range: 0–100) (one step increment increase) −0.039 0.019 0.962 0.044 0.926 to 0.999
Pain score at 1 month after discharge (range: 0–10) (one 
step increment increase)
0.270 0.089 1.310 0.003 1.099 to 1.560
PCS at 3 months (range: 0–100) (one step increment 
increase)
−0.051 0.015 0.951 0.001 0.922 to 0.980
Current pain score 3 months after discharge (range: 0–10) 
(one step increment increase)
0.219 0.084 1.245 0.009 1.057 to 1.467
Constant 1.361 1.098 – 0.215 –
Model 3: likely neuropathic component to pain at 6 months after hospital discharge
Commenced on pregabalin during hospital admission 2.340 1.156 10.377 0.043 1.076 to 100.113
MCS at 1 month after discharge (range: 0–100) (one step 
increment increase)
−0.058 0.026 0.944 0.026 0.897 to 0.993
Pain detect score at 3 months (range: −1 to 38) (one step 
increment increase)
0.174 0.043 1.190 <0.001 1.094 to 1.295
Impact of pain on mood at 3 months after discharge (range 
0–10) (one step increment increase)
0.192 0.095 1.212 0.043 1.212 to 1.006
Constant −1.421 1.188 – 0.232 –
MCS, Mental Component Score; PCS, Physical Component Score.
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into the recovery of this patient group within the UK. 
This study has identified the high levels of pain and poor 
physical function experienced after BTI in the UK and 
measured the presence of neuropathic pain components 
within this population. Although it was not possible to 
construct a predictive model using only clinically avail-
able baseline and discharge level variables, the process 
of predictive prognostic modelling has identified factors 
that predict outcomes. This suggests that it is possible to 
develop a risk stratification score, but acknowledges that 
there is limited clinical utility in these current models 
as the data required to achieve accurate predictions of 
outcomes is not routinely available in clinical practice. 
Further research is needed to understand how clinically 
useful prediction models can be developed for this popu-
lation. There is potential, with refinement, to make the 
current prediction models more clinically useful, and 
there are ways that this score could have clinical utility in 
identifying patients at risk of poor functional outcomes 
or chronic/neuropathic pain, subject to external valida-
tion in a future study. In respect to the models presented 
in this study, it is important to remember that good 
model performance in a development sample does 
not necessarily mean good predictive abilities in a new 
external validation data set.
The limitations of using generic patient- reported 
outcome measures (PROMs) to measure HRQoL have 
been reported previously.7 35 Although validated within 
the major trauma population, it remains unclear how 
specific and comprehensive generic outcome measures 
(eg, SF-12 and EQ- 5D- 5L) are in groups like the BTI 
population. Although a trauma PROM has previously 
been developed,36 there is a need for injury specific 
measures, particularly where unique outcomes have been 
identified.7 37 Physical functioning was measured at a 
global level in this study using the SF-12 PCS and using 
the individual levels of the EQ- 5D- 5L questionnaire. Both 
measures highlighted the extent of the altered physical 
function experienced by this population, which had not 
returned to their perceived baseline level of function at 
6 months. In previous non- UK research, sequela related 
to BTI has been measured up to 2 years after injury high-
lighting the long- term impact of BTI.38 Due to funding, 
it was not possible to extend the follow- up in the current 
study, but the 6- month time point was clinically ideal for 
the prognostic modelling process, particularly as Marasco 
Figure 1 Receiver operator curve (ROC) for predictive models for three outcomes of interest.
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et al highlighted that patients reporting poor physical 
function at 6 months after injury reported poor physical 
function at 1 year and greater odds of reporting poor 
physical function at 2 years after injury.38
One key factor that influences HRQoL after BTI is 
pain, and the efficacy of pain management.6 Measures of 
pain severity within this study highlighted 43.1% (n=91) 
of participants reported pain that was moderate, severe or 
extreme at 6 months after hospital discharge with a mean 
PSS of 2.7 (SD 2.7). For these participants, the mean anal-
gesic effectiveness was 49.2 (SD 33.4) demonstrating how 
a chronic pain state existed where analgesic agents were 
not effective in managing pain. The variables in model 
2 demonstrate the complexity in chronic pain manage-
ment particularly in identifying those at risk through 
the predictive modelling process. Within this model it 
was not possible to predict the likelihood of whether a 
participant would experience chronic pain at 6 months 
after discharge using clinically available variables only. 
The final model included variables from pre- injury esti-
mates through to 3 months after discharge which high-
lighted the need to alter our current model for patient 
follow- up to enable measurements at 1 and 3 months 
after discharge. Unsurprisingly, participants using regular 
analgesic agents prior to their injury had an OR>6 high-
lighting the need to identify patients with pre- existing 
chronic pain states during hospital admission as these 
patients are most likely to have ongoing injury- related 
pain requirements at 6 months after hospital discharge.
There were greater odds of reporting neuropathic pain 
at 6 months if the participant had been initiated on a 
neuropathic pain agent (eg, pregabalin) during the acute 
hospital admission. This suggests that clinical teams and 
specialist pain teams are accurately identifying patients 
at risk of neuropathic pain and commencing treatment. 
This unfortunately also highlights that these patients are 
still progressing to develop symptoms of neuropathic 
pain at 6 months after discharge which suggests that 
greater input from specialist pain services after hospital 
discharge may be required to manage this pain trajectory. 
The model for neuropathic pain highlights an associa-
tion with the MCS of the SF-12 at 1 month and the effect 
of pain on mood at 3 months after hospital discharge. 
The relationship between neuropathic pain and mental 
health has previously been identified in the non- trauma 
literature.39 Although there was a less substantial drop 
in SF-12 MCS compared with the PCS and this returned 
to the pre- injury baseline within the 6- month follow- up 
period, this shows the importance of measuring mental 
well- being as both a part of HRQoL and as an important 
predictor of neuropathic pain.
This study has developed a model for each of the three 
outcomes of interest: physical function, chronic pain and 
neuropathic pain at 6 months after hospital discharge with 
BTI. The next phase of the modelling process will be to 
conduct a further study to validate the predictive ability of 
the models within an external sample of participants with 
BTI. This study will further explore the follow- up needs of 
patients with BTI and look at effective ways of collecting 
these data needed to predict 6- month outcomes. It will 
also be of interest to investigate these outcomes beyond 
the 6 months follow- up period used in this study. In the 
Figure 2 Calibration plot for model using expected and observed probabilities of developing poor outcomes.
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meantime, these predictive variables have clinical utility 
for clinicians reviewing patients during the follow- up 
period in primary and secondary care settings and these 
variables may be useful in highlighting patients at risk 
who need referral to specialist services (eg, physiotherapy 
or specialist pain services).
Strengths and limitations of this study
Although we recruited a moderate sized sample using the 
exploratory approach to this study, we did not achieve 
the aim of recruiting 100 events relating to our three 
outcomes of interest. Care was taken to ensure that 
that the number of variables inputted into each model 
were justified by the number participants reporting the 
outcomes of interest. There are reports within the liter-
ature that the arbitrary rule of 10 cases per variable does 
not necessarily negatively impact on the model fit.40 
During subsequent validation of the models, care will be 
taken to assess for overfitting of the models but from the 
model diagnostics presented here, there is no suggestion 
of overfitting within the current sample.32 It is important 
to remember that the final models are to some degree 
variable selection method dependent. In an ideal world, it 
would have been beneficial to use more than one method 
of selection but in the case of this study, it was not possible 
to undertake backward selection because of concerns of 
overfitting the model.
Overall, the combined response rate of 72% at all time 
points is comparable to equivalent studies undertaken 
previously in this area of trauma research.6 Despite this, 
the response rate was a limitation as the key outcomes 
were measured at the 6- month time point resulting in 
only 63% (n=211) of the overall recruited sample being 
included in the modelling process. For further studies 
investigating outcomes within a longitudinal follow- up 
process, it will be important to use these data to consider 
potential sample sizes required to adequately power these 
studies.
Although multiple imputation was used in the manage-
ment of missingness for independent variables, it is 
acknowledged that the case wise deletion approach used 
in the management of missingness in the outcome data 
are a limitation in this study. In the presence of MAR 
data, this approach results in large proportions of data 
being discarded, which results in the introduction of 
potential bias, and reduced precision and power. For this 
reason, and despite there being no clinically significant 
differences between the characteristics of responders 
and non- responders, the findings of this study should 
be interpreted cautiously. Despite all efforts to maximise 
response rates at all time points, future longitudinal 
studies in the BTI population will need to consider other 
ways of accessing patients to facilitate complete follow- up 
data collection in a geographically diverse population.
As subjective outcome measures have been used 
throughout this study, it is important to acknowledge the 
risk of bias which is inherent within these measures, partic-
ularly in relation to participants selecting the extremes of 
a rating scale.41 Care has been taken within the study to 
control this bias through the instructions given to patients 
prior to completing each questionnaire and investigation 
of outliers within the sample during data analysis.42 In 
future research, it would be interesting to compare the 
predictive ability of both subjective outcomes (ie, SF-12 
PCS for physical function) with an objective measure 
(grip strength testing as an estimate of physical functional 
ability for example) and compare the difference in the 
predictive functions of these outcomes.43
Finally, although most of the study was undertaken 
before the COVID-19 pandemic began in the UK, there will 
be seen and unseen impacts of the COVID-19 pandemic 
on this study.44 The final three sites closed to recruitment 
2–4 weeks early causing them to not meet recruitment 
targets. Furthermore, follow- up continued throughout 
the first wave of the pandemic in the UK. Although we 
were not able to collect data relating COVID-19 infection 
among our sample, we were not informed that any partici-
pants had been infected with the virus. Despite this, there 
is potential bias relating to lockdown, social isolation 
that remains unmeasured within our sample which may 
have impacted on the self- reported outcome measures 
reported in this study.45
CONCLUSIONS
It remains vital that the interdisciplinary team do not 
underestimate the impact of the long- term outcomes 
associated with BTI, particularly relating to physical func-
tioning, chronic pain and neuropathic pain. Although 
predictive models were successfully developed, this study 
has demonstrated the complexity and challenge of devel-
oping models which are clinically useful as many of the 
variables included in these final models are not routinely 
available in practice. Despite this, the study has shown 
how predictive models can be developed for outcomes 
and highlight how PROMs can be used to develop prog-
nostic models particularly in longitudinal processes 
where objective clinical data are not routinely collected. 
Ultimately, these models add to our understanding of 
which factors influence the development of sequela after 
hospital discharge with BTI and after external validation, 
will have clinical utility in the risk stratification of high- 
risk patient groups.
Author affiliations
1Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's 
College London, London, UK
2Emergency Department, King's College Hospital, London, UK
3Welsh Institute of Biomedical and Emergency Medicine Research, Swansea Bay 
University Health Board, Port Talbot, UK
4Emergency Department, Buckingham Healthcare NHS Trust, Amersham, UK
5Emergency Department, North Bristol NHS Trust, Westbury on Trym, UK
6Emergency Department, Surrey and Sussex Healthcare NHS Trust, Redhill, UK
7Department of Anesthetics, Aneurin Bevan Health Board, Newport, UK
8Critical Care, King's College Hospital NHS Foundation Trust, London, UK
9Emergency Department, Barnsley Hospital NHS Foundation Trust, Barnsley, UK
10Emergency Department, St George's Healthcare NHS Trust, London, UK
11General Surgery, Aneurin Bevan Health Board, Newport, UK
13Baker E, et al. BMJ Open 2021;11:e049292. doi:10.1136/bmjopen-2021-049292
Open access
12Emergency Department, Barts Health NHS Trust, London, UK
13Emergency Department, University Hospitals of Derby and Burton NHS Foundation 
Trust, Derby, UK
14Emergency Department, King's College Hospital NHS Foundation Trust, London, UK
15Emergency Department, Imperial College Healthcare NHS Trust, London, UK
Twitter Edward Baker @edbaker_ed, Ceri Battle @ceribattle, Imogen Skene @
ImogenSkene, Andrew Tabner @andrewtabner, Malcolm Tunnicliff @malcolm1771, 
Louise Young @NurseLouiseY and Andreas Xyrichis @AndreasXyrichis
Acknowledgements The research team would like to acknowledge the study 
participants who gave up their time to participate in this interview study and the 
clinical research staff at each site who contributed to the participants recruitment 
and initial data collection for the Rib Injury Outcomes Study.
Contributors EB, GL, AX, CN and PH conceived and designed the study and 
developed the study protocol. AB, CB, EC, CD, JF, RJ, LP, AR, IS, AT, MT and LY 
were local primary investigators and coordinated and contributed significantly to 
the recruitment and data collection processes. Data analysis was planned with 
EB, GL, TM and CB. Data analysis was undertaken by EB and reviewed by TM. EB 
developed the first draft of the manuscript and EC, CB, AX, CN, PH and GL made 
subsequent revisions. All authors commented on and approved the manuscript prior 
to submission for publication. EB takes overall responsibility for the manuscript.
Funding EB is funded by a National Institute for Health Research (NIHR), Clinical 
Doctoral Research Fellowship for this research project (ICA- CDRF-2016-02-006). 
The publication presents independent research funded by the NIHR. The views 
expressed are those of the authors and not necessarily those of the National Health 
Service, the NIHR or the Department of Health and Social Care.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval Ethical approval was granted by the ‘Hampshire A’ South Central 
Research Ethics Committee in June 2018 (ref: 18/SC/0230).
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the 
article or uploaded as supplementary information. The authors confirm that the 
data supporting the findings of this study are available within the article and its 
supplementary materials.
Supplemental material This content has been supplied by the author(s). It has 
not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been 
peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCID iDs
Edward Baker http:// orcid. org/ 0000- 0002- 2633- 0871
Imogen Skene http:// orcid. org/ 0000- 0001- 5215- 2899
Andrew Tabner http:// orcid. org/ 0000- 0003- 4191- 9024
Andreas Xyrichis http:// orcid. org/ 0000- 0002- 2359- 4337
REFERENCES
 1 Baker EJ, Lee GA. A retrospective observational study examining 
the effect of thoracic epidural and patient controlled analgesia on 
short- term outcomes in blunt thoracic trauma injuries. Medicine 
2016;95:e2374.
 2 Battle C, Hutchings H, Lovett S, et al. Predicting outcomes after 
blunt chest wall trauma: development and external validation of a 
new prognostic model. Crit Care 2014;18:R98.
 3 de Graaf MW, Reininga IHF, Heineman E, et al. The development 
and internal validation of a model to predict functional recovery after 
trauma. PLoS One 2019;14:e0213510.
 4 Cole E, Lecky F, West A, et al. The impact of a Pan- regional inclusive 
trauma system on quality of care. Ann Surg 2016;264:188–94.
 5 Martino C, Russo E, Santonastaso DP, et al. Long- Term outcomes in 
major trauma patients and correlations with the acute phase. World J 
Emerg Surg 2020;15:6.
 6 Baker E, Xyrichis A, Norton C, et al. The long- term outcomes and 
health- related quality of life of patients following blunt thoracic injury: 
a narrative literature review. Scand J Trauma Resusc Emerg Med 
2018;26:67.
 7 Craxford S, Deacon C, Myint Y, et al. Assessing outcome measures 
used after rib fracture: a COSMIN systematic review. Injury 
2019;50:1816–25.
 8 Wilson IB, Cleary PD. Linking clinical variables with health- related 
quality of life. A conceptual model of patient outcomes. JAMA 
1995;273:59–65.
 9 Ojelabi AO, Graham Y, Haighton C, et al. A systematic review of the 
application of Wilson and Cleary health- related quality of life model in 
chronic diseases. Health Qual Life Outcomes 2017;15:241.
 10 Baker E, Woolley A, Xyrichis A, et al. How does the implementation 
of a patient pathway- based intervention in the acute care of blunt 
thoracic injury impact on patient outcomes? A systematic review of 
the literature. Injury 2020;51:1733–43.
 11 Karimi M, Brazier J. Health, health- related quality of life, and quality 
of life: what is the difference? Pharmacoeconomics 2016;34:645–9.
 12 Vernon D, Brown JE, Griffiths E, et al. Reducing readmission 
rates through a discharge follow- up service. Future Healthc J 
2019;6:114–7.
 13 Braaf S, Ameratunga S, Nunn A, et al. Patient- identified information 
and communication needs in the context of major trauma. BMC 
Health Serv Res 2018;18:163.
 14 Keene DJ, Vadher K, Willett K, et al. Predicting patient- reported 
and objectively measured functional outcome 6 months after 
ankle fracture in people aged 60 years or over in the UK: 
prognostic model development and internal validation. BMJ Open 
2019;9:e029813.
 15 Baker E, Xyrichis A, Norton C, et al. The processes of hospital 
discharge and recovery after blunt thoracic injuries: the patient's 
perspective. Nurs Open 2021. doi:10.1002/nop2.929. [Epub ahead of 
print: 18 May 2021].
 16 Ware J, Kosinski M, Keller SD. A 12- Item short- form health survey: 
construction of scales and preliminary tests of reliability and validity. 
Med Care 1996;34:220–33.
 17 Devlin NJ, Parkin D, Browne J. Patient- reported outcome measures 
in the NHS: new methods for analysing and reporting EQ- 5D data. 
Health Econ 2010;19:886–905.
 18 Parkin D, Rice N, Devlin N. Statistical analysis of EQ- 5D profiles: 
does the use of value sets bias inference? Med Decis Making 
2010;30:556–65.
 19 Kumar SP. Utilization of brief pain inventory as an assessment tool 
for pain in patients with cancer: a focused review. Indian J Palliat 
Care 2011;17:108–15.
 20 Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new 
screening questionnaire to identify neuropathic components in 
patients with back pain. Curr Med Res Opin 2006;22:1911–20.
 21 Battle CE, Hutchings H, James K, et al. The risk factors for the 
development of complications during the recovery phase following 
blunt chest wall trauma: a retrospective study. Injury 2013;44:1171–6.
 22 Treede R- D, Rief W, Barke A, et al. A classification of chronic pain for 
ICD-11. Pain 2015;156:1003–7.
 23 Boonstra AM, Schiphorst Preuper HR, Balk GA, et al. Cut- off 
points for mild, moderate, and severe pain on the visual analogue 
scale for pain in patients with chronic musculoskeletal pain. Pain 
2014;155:2545–50.
 24 Murnion BP. Neuropathic pain: current definition and review of drug 
treatment. Aust Prescr 2018;41:60–3.
 25 Mathieson S, Lin C. painDETECT questionnaire. J Physiother 
2013;59:211.
 26 Unsworth A, Curtis K, Asha SE. Treatments for blunt chest trauma 
and their impact on patient outcomes and health service delivery. 
Scand J Trauma Resusc Emerg Med 2015;23:17.
 27 Kourouche S, Buckley T, Munroe B, et al. Development of a 
blunt chest injury care bundle: an integrative review. Injury 
2018;49:1008–23.
 28 von Elm E, Altman DG, Egger M, et al. The strengthening the 
reporting of observational studies in epidemiology (STROBE) 
statement: guidelines for reporting observational studies. Int J Surg 
2014;12:1495–9.
14 Baker E, et al. BMJ Open 2021;11:e049292. doi:10.1136/bmjopen-2021-049292
Open access 
 29 Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a 
multivariable prediction model for individual prognosis or diagnosis 
(TRIPOD): the TRIPOD statement. BMJ 2015;350:g7594.
 30 Pareek N, Kordis P, Beckley- Hoelscher N, et al. A practical risk score 
for early prediction of neurological outcome after out- of- hospital 
cardiac arrest: MIRACLE2. Eur Heart J 2020;41:4508–17.
 31 Shipe ME, Deppen SA, Farjah F, et al. Developing prediction models 
for clinical use using logistic regression: an overview. J Thorac Dis 
2019;11:S574–84.
 32 Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration 
of clinical prediction models: users' guides to the medical literature. 
JAMA 2017;318:1377–84.
 33 Ayilara OF, Zhang L, Sajobi TT, et al. Impact of missing data on bias 
and precision when estimating change in patient- reported outcomes 
from a clinical Registry. Health Qual Life Outcomes 2019;17:106.
 34 Schlomer GL, Bauman S, Card NA. Best practices for missing 
data management in counseling psychology. J Couns Psychol 
2010;57:1–10.
 35 Hoffman K, Cole E, Playford ED, et al. Health outcome after major 
trauma: what are we measuring? PLoS One 2014;9:e103082.
 36 Attenberger C, Amsler F, Gross T. Clinical evaluation of the trauma 
outcome profile (top) in the longer- term follow- up of polytrauma 
patients. Injury 2012;43:1566–74.
 37 Rosenberg GM, Stave C, Spain DA, et al. Patient- Reported 
outcomes in trauma: a scoping study of published research. Trauma 
Surg Acute Care Open 2018;3:e000202.
 38 Marasco S, Lee G, Summerhayes R, et al. Quality of life after major 
trauma with multiple rib fractures. Injury 2015;46:61–5.
 39 Torta R, Ieraci V, Zizzi F. A review of the emotional aspects of 
neuropathic pain: from comorbidity to Co- Pathogenesis. Pain Ther 
2017;6:11–17.
 40 Ogundimu EO, Altman DG, Collins GS. Adequate sample size for 
developing prediction models is not simply related to events per 
variable. J Clin Epidemiol 2016;76:175–82.
 41 Dowling NM, Bolt DM, Deng S, et al. Measurement and control 
of bias in patient reported outcomes using multidimensional item 
response theory. BMC Med Res Methodol 2016;16:63.
 42 Tempelaar D, Rienties B, Nguyen Q. Subjective data, objective data 
and the role of bias in predictive modelling: lessons from a dispositional 
learning analytics application. PLoS One 2020;15:e0233977.
 43 Koskinen S, Hokkinen E- M, Wilson L, et al. Comparison of subjective 
and objective assessments of outcome after traumatic brain injury 
using the International classification of functioning, disability and 
health (ICF). Disabil Rehabil 2011;33:2464–78.
 44 Baker E, Lee G. Reflecting on the challenges of sustaining 
emergency care research during the Covid-19 pandemic. Int Emerg 
Nurs 2020;51:100894.
 45 Baker E, Clark LL. Biopsychopharmacosocial approach to assess 
impact of social distancing and isolation on mental health in older 
adults. Br J Community Nurs 2020;25:231–8.
